SlideShare a Scribd company logo
1 of 34
VENTRICULAR TACHYCARDIAS
Shirjeel Murtaza
V. TACHYCARDIA
• 3 or More consecutive QRS complexes of ventricular
origin at a rate of > 100 beats / min
• VTs arise distal to bifurcation of HIS bundle
• THREE MECHANISMs
– RE-ERNTRY (90 % VT with IHD)
– AUTOMATICITY ( escape rhythms, idiopathic VTs )
– TRIGGERED ( digitalis , catecholaminergic )
Some TERMS
• Sustained
– For More than 30 seconds
• Non Sustained
– For Less than 30 seconds
• Frequent PVCs
– > 5 / minute
– > 30 / hour
• Occasional PVCs
NOW WHAT TO DO ?
Wide Complex Tachycardias
• Any WCT in a patient with IHD is VT
• If you don’t know the reason, its VT
• Horizontal entry of patient in ER, is VT
Wide Complex Tachycardias
• Regular
– VT
– Abberant ventricular conduction
– Preexisting LBBB or RBBB
– Preexisting Nonspecific Intra ventricular conduction defects
– Anterograde conduction with pre excitation ( WPW with antedromic AVRT )
– Anterograde conduction over atriofascicular or nodo ventricular connection
• Irregular
– A Fib with abberant conduction/ BBB/ IVCD
– A fib with venricular pre excitation
– Polymorphic VT ( catecholaminergic )
– Torsade de Pointes
Differentiating points
VT
History of MI
AV dissociation ( Pathognomic )
Capture beats
Fusion beats
Extreme Axis
Very Broad complexes ( > 140 ms )
No response to Vagal manouvers or adenosine
Fusion beat• Marriot et al Criteria
1. Contour and Duration of QRS are intermediate
2. PR of Fusion < PR of supraventricular complex
3. PS (PJ) of Fusion > PR of supraventricular complex
4. Vector of Fusion complex is always different from
supraventricular
• EXCEPTIONs
– BBB/ IVCD/ SVT with variable Av conduction times
Capture beat
• Normal Contour
• Slightly pre mature
How to Assess a WCT
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
BRUGADA (1991)
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
SVT WITH ABBERANCY
RS100PM
Brugada’s sign
V1,2,6 Based Criteria
used by BRUGADA
• Wellens Criteria for VT-RBBB (1978)
– V1
• Monophasic R
• Biphasic qR, QR, RS
– V6
• rS , QS , qR
• Kindwall Criteria for VT-LBBB(1988)
– V1 & V2
• R > 30ms
– V1 & V2 Start of q to nadir of s > 60ms
– Notch on Downslop of S in V1 / V2
– Any Q in V6
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
V1,2,6 Based Criteria
used by BRUGADA
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
LBBB
• Delayed onset of intrinsicoid deflection in leads I, V5, V6
• Broad monophasic R waves in leads I, V5, V6 that are
usually notched or slurred
• rS or QS complex in right precordial leads
RBBB
• rsR’ or rSR
• Delayed onset of intrinsicoid deflection (beginning
of QRS to peak of R wave > 0.05 seconds) in V1
and V2
• Wide slurred S wave in leads I, V5, and V6
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
QRSP
Vereckei et al
aVR40nv
Wide Complex Tachycardias
• Any WCT in a patient with IHD is VT
• If you don’t know the reason, its VT
• Horizontal entry of patient in ER, is VT
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
STEP 1
STEP 2
Tip shows the origin
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
Special VT types
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
Lead iii ulti
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
• General Management
– Unstable
• DCC
– Synchronous for VT with pulse; Asynchronus for pulseless VT
– Stable
• Medical initiallly
• Search reversible cause and correct
– Ischemia
– Electrolyte imbalance
– Bradycardia
– Hypotension
– drugs
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
• Acute medical therapy
– Amiodarone ( agent of choice )
– Lidocaine ( ischemic origin )
– Procainamide
– B blockers ( for ACS, idiopathic RVOT )
– Calcium channel blockers ( RVOT, fascicular and digitalis )
– MgSO4 ( Torsade de pointes )
– Sodium Bicarbonate ( Acidosis ; TCA )
• RFA ( Curative for 90% of idiopathic VT )
• Surgical ablation ( for scar VT; with aneurysmectomy )
• ATP ( anti tachycardia pacing )
• Alcohol injection in coronary branch for the area
• Prevention
– B blockers ( primary )
– ICD ( primary and secondary )
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
Amiodarone
• Intravenous infusion
– Initial 5 mg/ kg over 20-120 minutes with ecg
monitoring; subsequent infusion given if necessary
according to response upto max. 1.2 g in 24 hours
• Pulseless VT or V fib. ( ACLS )
– Pre filled syringe or 300 mg diluted in 20 ml glucose 5
% after adrenaline if refractory to defibrillation.
Additional dose of 150 mg can be given by IV injection
if nececcary followed by infusion of 900 mg over 24
hours
Reference; BNF 67
Amiodaroone
• 5mg / kg bolus = 300 mg for 60 kg person
• INFUSION
– 1 mg / min for 6 hours
– ½ mg /min for 18 hours
24 hours
2 injections ( 300 mg ) in 100 ml burrette at 20 microdrops / min for 6 hours
then
At 10 microdrops for 18 hours
Amiodarone
• Oral
– Start: LOAD 800-1600mg PO qd x 1-3 wk until
response
• (for loading dose more than 1000mg / day divided w/
meals bid – tid)
– Maintenence
• 200-600 mg PO qd
• Divided bid-tid if GI intolerence
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
• Rate
• QRS duration
• Differentiate from SVT with Abberancy
• Differentiate from pre-exicitation
• Focus of VT
• Cause of VT
• Manage VT
Ventricular tachycardia
Ventricular tachycardia

More Related Content

What's hot

ECG #9 - ID594a - acute ASMI
ECG #9 - ID594a - acute ASMI ECG #9 - ID594a - acute ASMI
ECG #9 - ID594a - acute ASMI
Anas Nader
 
Stepwise interpretation of ECG - #9 no Dx ID 594
Stepwise interpretation of ECG - #9 no Dx ID 594Stepwise interpretation of ECG - #9 no Dx ID 594
Stepwise interpretation of ECG - #9 no Dx ID 594
Anas Nader
 

What's hot (20)

ECG #9 - ID594a - acute ASMI
ECG #9 - ID594a - acute ASMI ECG #9 - ID594a - acute ASMI
ECG #9 - ID594a - acute ASMI
 
ECG: Trifascicular Block
ECG: Trifascicular BlockECG: Trifascicular Block
ECG: Trifascicular Block
 
narrow QRS tachycardia diagnostic pacing maneuvers
narrow QRS tachycardia diagnostic pacing maneuversnarrow QRS tachycardia diagnostic pacing maneuvers
narrow QRS tachycardia diagnostic pacing maneuvers
 
IDIOPATHIC VT
IDIOPATHIC VTIDIOPATHIC VT
IDIOPATHIC VT
 
Stepwise interpretation of ECG - #9 no Dx ID 594
Stepwise interpretation of ECG - #9 no Dx ID 594Stepwise interpretation of ECG - #9 no Dx ID 594
Stepwise interpretation of ECG - #9 no Dx ID 594
 
Electrophysiology AVNRT
Electrophysiology AVNRTElectrophysiology AVNRT
Electrophysiology AVNRT
 
Case Presentataion-psvt
Case Presentataion-psvtCase Presentataion-psvt
Case Presentataion-psvt
 
Locke arrhythmia
Locke   arrhythmiaLocke   arrhythmia
Locke arrhythmia
 
ECG interpretation
ECG interpretationECG interpretation
ECG interpretation
 
Avrt vz vt
Avrt vz vtAvrt vz vt
Avrt vz vt
 
Papillary muscle-vt
Papillary muscle-vtPapillary muscle-vt
Papillary muscle-vt
 
Svt maneuvers hany abed
Svt maneuvers hany abedSvt maneuvers hany abed
Svt maneuvers hany abed
 
FASCICULAR VENTRICULAR TACHYCARDIA( VT)
FASCICULAR VENTRICULAR TACHYCARDIA( VT)FASCICULAR VENTRICULAR TACHYCARDIA( VT)
FASCICULAR VENTRICULAR TACHYCARDIA( VT)
 
Manifest paraHisian accessory pathway (wpw) ablation our experience
Manifest paraHisian accessory pathway (wpw) ablation our experience Manifest paraHisian accessory pathway (wpw) ablation our experience
Manifest paraHisian accessory pathway (wpw) ablation our experience
 
Basics of ecg
Basics of ecgBasics of ecg
Basics of ecg
 
Electrophysiology AVRT
Electrophysiology AVRTElectrophysiology AVRT
Electrophysiology AVRT
 
Localization of WPW( accessory Pathway) by surface ECG
Localization of WPW( accessory Pathway) by surface ECGLocalization of WPW( accessory Pathway) by surface ECG
Localization of WPW( accessory Pathway) by surface ECG
 
Complex svt with differentiation
Complex svt  with differentiationComplex svt  with differentiation
Complex svt with differentiation
 
SVT maneuvers
SVT maneuversSVT maneuvers
SVT maneuvers
 
Wolff - Parkinson - White Syndrome
Wolff - Parkinson - White SyndromeWolff - Parkinson - White Syndrome
Wolff - Parkinson - White Syndrome
 

Similar to Ventricular tachycardia

Approch narrow complex tachycardia
Approch narrow complex tachycardiaApproch narrow complex tachycardia
Approch narrow complex tachycardia
Dharam Prakash Saran
 

Similar to Ventricular tachycardia (20)

wide complex tachycardia.pptx
 wide complex tachycardia.pptx wide complex tachycardia.pptx
wide complex tachycardia.pptx
 
Approach to cardiac arrhythmias
Approach to cardiac arrhythmiasApproach to cardiac arrhythmias
Approach to cardiac arrhythmias
 
Approach to Wide QRS tachycardia.pptx
Approach to Wide QRS tachycardia.pptxApproach to Wide QRS tachycardia.pptx
Approach to Wide QRS tachycardia.pptx
 
Approach to a case of wide complex tachycardia
Approach to a case of wide complex tachycardiaApproach to a case of wide complex tachycardia
Approach to a case of wide complex tachycardia
 
Arrythmia-II.pptx
Arrythmia-II.pptxArrythmia-II.pptx
Arrythmia-II.pptx
 
Wide complex tachycardia
Wide complex tachycardiaWide complex tachycardia
Wide complex tachycardia
 
Ecg quiz @ SEMICON 1018
Ecg quiz @ SEMICON 1018Ecg quiz @ SEMICON 1018
Ecg quiz @ SEMICON 1018
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
QT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVAL
QT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVALQT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVAL
QT INTERVAL IN ECG,CAUSES OF SHORT AND LONG QT INTERVAL
 
Approch narrow complex tachycardia
Approch narrow complex tachycardiaApproch narrow complex tachycardia
Approch narrow complex tachycardia
 
Irregular wide qrs tachycardia
Irregular wide qrs tachycardiaIrregular wide qrs tachycardia
Irregular wide qrs tachycardia
 
Ventricular arrhythmias
Ventricular arrhythmiasVentricular arrhythmias
Ventricular arrhythmias
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Approach to Narrow complex tachycardia
Approach to Narrow complex tachycardiaApproach to Narrow complex tachycardia
Approach to Narrow complex tachycardia
 
Narrow qrs tachy i.tammi raju
Narrow qrs tachy i.tammi rajuNarrow qrs tachy i.tammi raju
Narrow qrs tachy i.tammi raju
 
Tachyarrhythmias
TachyarrhythmiasTachyarrhythmias
Tachyarrhythmias
 
ECG Analysis
ECG AnalysisECG Analysis
ECG Analysis
 
TACHYARRTHYMIA.pptx
TACHYARRTHYMIA.pptxTACHYARRTHYMIA.pptx
TACHYARRTHYMIA.pptx
 
Narrow complex tachycardia
Narrow complex tachycardia Narrow complex tachycardia
Narrow complex tachycardia
 
Arrhythmias
ArrhythmiasArrhythmias
Arrhythmias
 

More from ShirjeelMurtaza (8)

Endocarditis and rheumatic heart disease
Endocarditis and rheumatic heart diseaseEndocarditis and rheumatic heart disease
Endocarditis and rheumatic heart disease
 
V tach guidelines
V tach guidelinesV tach guidelines
V tach guidelines
 
Lupus pneumonitis
Lupus pneumonitisLupus pneumonitis
Lupus pneumonitis
 
pericardial effusion
pericardial effusionpericardial effusion
pericardial effusion
 
Portal hypertension
Portal hypertensionPortal hypertension
Portal hypertension
 
Ecg
EcgEcg
Ecg
 
Ecg 3
Ecg 3Ecg 3
Ecg 3
 
Ecg 2
Ecg 2Ecg 2
Ecg 2
 

Recently uploaded

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Recently uploaded (20)

UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 

Ventricular tachycardia

  • 2. V. TACHYCARDIA • 3 or More consecutive QRS complexes of ventricular origin at a rate of > 100 beats / min • VTs arise distal to bifurcation of HIS bundle • THREE MECHANISMs – RE-ERNTRY (90 % VT with IHD) – AUTOMATICITY ( escape rhythms, idiopathic VTs ) – TRIGGERED ( digitalis , catecholaminergic )
  • 3. Some TERMS • Sustained – For More than 30 seconds • Non Sustained – For Less than 30 seconds • Frequent PVCs – > 5 / minute – > 30 / hour • Occasional PVCs
  • 4. NOW WHAT TO DO ?
  • 5. Wide Complex Tachycardias • Any WCT in a patient with IHD is VT • If you don’t know the reason, its VT • Horizontal entry of patient in ER, is VT
  • 6. Wide Complex Tachycardias • Regular – VT – Abberant ventricular conduction – Preexisting LBBB or RBBB – Preexisting Nonspecific Intra ventricular conduction defects – Anterograde conduction with pre excitation ( WPW with antedromic AVRT ) – Anterograde conduction over atriofascicular or nodo ventricular connection • Irregular – A Fib with abberant conduction/ BBB/ IVCD – A fib with venricular pre excitation – Polymorphic VT ( catecholaminergic ) – Torsade de Pointes
  • 7. Differentiating points VT History of MI AV dissociation ( Pathognomic ) Capture beats Fusion beats Extreme Axis Very Broad complexes ( > 140 ms ) No response to Vagal manouvers or adenosine
  • 8. Fusion beat• Marriot et al Criteria 1. Contour and Duration of QRS are intermediate 2. PR of Fusion < PR of supraventricular complex 3. PS (PJ) of Fusion > PR of supraventricular complex 4. Vector of Fusion complex is always different from supraventricular • EXCEPTIONs – BBB/ IVCD/ SVT with variable Av conduction times
  • 9. Capture beat • Normal Contour • Slightly pre mature
  • 10.
  • 11. How to Assess a WCT • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT
  • 12. BRUGADA (1991) • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT SVT WITH ABBERANCY RS100PM Brugada’s sign
  • 13. V1,2,6 Based Criteria used by BRUGADA • Wellens Criteria for VT-RBBB (1978) – V1 • Monophasic R • Biphasic qR, QR, RS – V6 • rS , QS , qR • Kindwall Criteria for VT-LBBB(1988) – V1 & V2 • R > 30ms – V1 & V2 Start of q to nadir of s > 60ms – Notch on Downslop of S in V1 / V2 – Any Q in V6 • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT
  • 14. V1,2,6 Based Criteria used by BRUGADA • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT LBBB • Delayed onset of intrinsicoid deflection in leads I, V5, V6 • Broad monophasic R waves in leads I, V5, V6 that are usually notched or slurred • rS or QS complex in right precordial leads RBBB • rsR’ or rSR • Delayed onset of intrinsicoid deflection (beginning of QRS to peak of R wave > 0.05 seconds) in V1 and V2 • Wide slurred S wave in leads I, V5, and V6
  • 15. • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT QRSP
  • 17. Wide Complex Tachycardias • Any WCT in a patient with IHD is VT • If you don’t know the reason, its VT • Horizontal entry of patient in ER, is VT
  • 18. • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT STEP 1 STEP 2 Tip shows the origin
  • 19. • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT
  • 20. • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT
  • 21. • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT
  • 23. • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT Lead iii ulti
  • 24. • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT
  • 25. • General Management – Unstable • DCC – Synchronous for VT with pulse; Asynchronus for pulseless VT – Stable • Medical initiallly • Search reversible cause and correct – Ischemia – Electrolyte imbalance – Bradycardia – Hypotension – drugs • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT
  • 26. • Acute medical therapy – Amiodarone ( agent of choice ) – Lidocaine ( ischemic origin ) – Procainamide – B blockers ( for ACS, idiopathic RVOT ) – Calcium channel blockers ( RVOT, fascicular and digitalis ) – MgSO4 ( Torsade de pointes ) – Sodium Bicarbonate ( Acidosis ; TCA ) • RFA ( Curative for 90% of idiopathic VT ) • Surgical ablation ( for scar VT; with aneurysmectomy ) • ATP ( anti tachycardia pacing ) • Alcohol injection in coronary branch for the area • Prevention – B blockers ( primary ) – ICD ( primary and secondary ) • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT
  • 27. Amiodarone • Intravenous infusion – Initial 5 mg/ kg over 20-120 minutes with ecg monitoring; subsequent infusion given if necessary according to response upto max. 1.2 g in 24 hours • Pulseless VT or V fib. ( ACLS ) – Pre filled syringe or 300 mg diluted in 20 ml glucose 5 % after adrenaline if refractory to defibrillation. Additional dose of 150 mg can be given by IV injection if nececcary followed by infusion of 900 mg over 24 hours Reference; BNF 67
  • 28. Amiodaroone • 5mg / kg bolus = 300 mg for 60 kg person • INFUSION – 1 mg / min for 6 hours – ½ mg /min for 18 hours 24 hours 2 injections ( 300 mg ) in 100 ml burrette at 20 microdrops / min for 6 hours then At 10 microdrops for 18 hours
  • 29. Amiodarone • Oral – Start: LOAD 800-1600mg PO qd x 1-3 wk until response • (for loading dose more than 1000mg / day divided w/ meals bid – tid) – Maintenence • 200-600 mg PO qd • Divided bid-tid if GI intolerence
  • 30. • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT
  • 31. • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT
  • 32. • Rate • QRS duration • Differentiate from SVT with Abberancy • Differentiate from pre-exicitation • Focus of VT • Cause of VT • Manage VT